This multi dimensional approach is changing lives. Learn how it can support your health journey.
Cancer rates are projected to affect one in two individuals, but there is hope. Discover a comprehensive, science-backed approach that combines four powerful strategies:
ALDH4A1, GcMAF, Fenbendazole, and Ivermectin: A Comprehensive Approach to Cancer Treatment
With cancer projected to affect one in two individuals at some point in their lives, a more comprehensive and powerful approach to prevention and treatment is urgently required. This article explores a potent combination of four promising therapies: ALDH4A1, GcMAF, Fenbendazole, and Ivermectin—each offering unique mechanisms of action that, when combined, provide a synergistic and holistic approach to cancer prevention and treatment.
ALDH4A1: Supporting Mitochondrial Function
ALDH4A1 (Aldehyde Dehydrogenase 4 Family, Member A1) is a mitochondrial enzyme that plays a pivotal role in cellular energy production and metabolic stability. Researchers at Duke University have highlighted its critical function in maintaining healthy mitochondrial function, which is essential for cellular health and cancer prevention.
How ALDH4A1 Protects Cells:
Mitochondrial Energy Regulation: ALDH4A1 stabilizes the mitochondrial pyruvate carrier (MPC) complex, ensuring efficient energy production through the tricarboxylic acid (TCA) cycle.
Preventing Metabolic Reprogramming: By maintaining proper mitochondrial function, ALDH4A1 prevents cancer cells from switching to a glycolytic (sugar-dependent) metabolism, a hallmark of aggressive tumors known as the Warburg effect.
Tumor Suppression: Loss of ALDH4A1 has been linked to impaired mitochondrial function and cancerous growth. Restoring its function can help suppress tumor development.
Supporting ALDH4A1 Naturally:
Dietary Proline: Since ALDH4A1 is involved in proline metabolism, consuming proline-rich foods such as bone broth, collagen, and grass-fed meat can support its function.
Mitochondrial Health Supplements:
Alpha-Lipoic Acid (600 mg daily).
Coenzyme Q10 (200 mg daily).
N-Acetyl Cysteine (600 mg twice daily).
Magnesium Glycinate (400 mg daily).
Exercise: Regular moderate aerobic exercise helps maintain mitochondrial function.
GcMAF: Boosting Immune Surveillance
GcMAF (Gc Macrophage Activating Factor) is a naturally occurring protein that activates macrophages, white blood cells responsible for identifying and eliminating abnormal cells, including cancer cells. In cancer patients, this natural immune surveillance can become compromised.
How GcMAF Works:
Macrophage Activation: GcMAF activates dormant macrophages, enhancing their ability to recognize and destroy cancer cells.
Reducing Inflammation: It modulates immune function, lowering chronic inflammation, which is a known driver of cancer progression.
Supporting Tissue Repair: GcMAF helps maintain tissue health, protecting against cellular damage.
Administration Protocol:
Dosage: 2500 ng injected daily for three months.
Expected Benefits:
Enhanced immune function and cancer cell recognition.
Reduced inflammation, creating a healthier cellular environment.
Improved patient energy and well-being.
Fenbendazole: Targeting Cancer at the Cellular Level
Fenbendazole, a broad-spectrum antiparasitic, has gained recognition for its potential anti-cancer properties. Although initially developed for veterinary use, Fenbendazole has demonstrated the ability to inhibit cancer cell growth by disrupting cellular microtubules.
Mechanism of Action:
Disrupting Microtubules: Fenbendazole prevents cancer cell division, leading to apoptosis (programmed cell death).
Enhancing Cellular Immunity: By impairing cancer cell structure, it makes them more recognizable to the immune system.
Synergistic Potential: Works well in combination with GcMAF and ALDH4A1 support.
Administration Protocol:
222 mg of Fenbendazole daily, taken on an empty stomach for 34 days.
May be used with antioxidant support (e.g., Vitamin E, Curcumin).
Safety Profile:
Well-tolerated in most patients with limited side effects.
Should be used under medical supervision, especially when combined with other therapies.
Ivermectin: A Multi-Purpose Antiparasitic with Anti-Cancer Potential
Ivermectin is another antiparasitic medication with emerging anti-cancer properties. Beyond its traditional use for parasitic infections, Ivermectin has been shown to inhibit cancer cell growth and promote apoptosis.
Mechanism of Action:
Inhibiting Cancer Cell Proliferation: It modulates WNT/β-catenin signaling, which is critical for cancer cell growth.
Supporting Immune Function: Enhances the ability of the immune system to identify and destroy cancer cells.
Complementing Mitochondrial Health: Its benefits align with ALDH4A1’s mitochondrial support.
Administration Protocol:
200–400 mcg/kg daily, typically taken with food.
Treatment duration may vary depending on the patient’s condition.
Safety Profile:
Well-tolerated when used at recommended doses.
Regular monitoring is advised when used long-term.
A Synergistic Cancer Protocol:
This protocol combines the unique strengths of ALDH4A1, GcMAF, Fenbendazole, and Ivermectin for a multi dimensional approach to cancer prevention and treatment:
ALDH4A1: Maintains healthy mitochondrial function, preventing the metabolic reprogramming seen in cancer cells.
GcMAF: Enhances immune surveillance, improving recognition and destruction of cancer cells.
Fenbendazole: Directly inhibits cancer cell growth by disrupting their cellular structure.
Ivermectin: Further supports immune function and directly impairs cancer cell survival.
Protocol Overview:
Morning: Take ALDH4A1 support supplements (Proline, CoQ10, Alpha-Lipoic Acid).
Midday: Administer Ivermectin with food.
Morning: Administer GcMAF (subcutaneously). 2500ng.
Daily: Fenbendazole (222 mg) on an empty stomach.
Expected Benefits:
Improved cellular energy through mitochondrial support.
Enhanced immune function, increasing cancer cell recognition and destruction.
Direct inhibition of cancer cell growth through Fenbendazole and Ivermectin.
Reduced inflammation, promoting a healthier cellular environment.
Conclusion:
With cancer rates projected to affect one in two individuals, a new approach is essential. This comprehensive protocol, combining ALDH4A1, GcMAF, Fenbendazole, and Ivermectin, provides a powerful, scientifically supported alternative for cancer prevention and treatment. By targeting cancer on multiple levels immune support, mitochondrial health, and direct cellular inhibition, this approach offers a safe and effective strategy for those seeking innovative solutions.
If you have any interest in parasites, Feel free to join https://www.facebook.com/groups/711577811230403/
Feel free to join https://www.facebook.com/groups/2053703715028393/
Written by Maryjayne Aria